Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Single-Fraction Very Accelerated Partial Breast Irradiation (sfVAPBI) in Low-Risk Invasive or Ductal In Situ Breast Carcinoma - Phase II Multicenter Trial

NCT07067437 is registered in ClinicalTrials.gov with National Institute of Oncology, Hungary as lead sponsor.

NCT NCT07067437
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07067437 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Single-Fraction Very Accelerated Partial Breast Irradiation (sfVAPBI) in Low-Risk Invasive or Ductal In Situ Breast Carcinoma - Phase II Multicenter Trial
Lead sponsor
National Institute of Oncology, Hungary
Phase
Not applicable
Overall status
Recruiting
Start date
July 1, 2025
Completion date
August 1, 2032
Enrollment
250 (estimated)
Sites
23

Conditions

As the registry lists them; a condition with its own page is linked.

breast neoplasms